Activation of the Hemostatic System During Cardiopulmonary Bypass, Anesth Analg. déc, vol.113, issue.6, pp.1319-1352, 2011. ,
,
The Prevalence and Impact of Preoperative Anemia in Patients Undergoing Cardiac Surgery for Rheumatic Heart Disease, J Cardiothorac Vasc Anesth. août, vol.30, issue.4, pp.896-900, 2016. ,
The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK -the first Association of Cardiothoracic Anaesthetists national audit, Anaesthesia. juin, vol.71, issue.6, pp.627-662, 2016. ,
Does the severity of preoperative anemia or blood transfusion have a stronger impact on long-term survival after cardiac surgery?, J Thorac Cardiovasc Surg, vol.152, issue.5, pp.1412-1432, 2016. ,
Meta-analysis of the association between preoperative anaemia and mortality after surgery: Preoperative anaemia and mortality after surgery, Br J Surg, vol.102, issue.11, pp.1314-1338, 2015. ,
Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study, Circulation. 29 janv, vol.117, issue.4, pp.478-84, 2008. ,
The Effect of Preoperative Anemia on the Outcome After Coronary Surgery, World J Surg. juill, vol.41, issue.7, pp.1910-1918, 2017. ,
Dixsept ans d'hémovigilance en France : bilan, perspectives, Transfus Clin Biol. avr, vol.18, issue.2, pp.140-50, 2011. ,
Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From, Transfus Med Rev. janv, vol.32, issue.1, pp.16-27, 2007. ,
, Noninfectious Serious Hazards of Transfusion: Anesth Analg. mars, vol.108, issue.3, pp.759-69, 2009.
,
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery. Circulation, vol.116, pp.2544-52, 2007. ,
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*, Crit Care Med. juin, vol.34, issue.6, pp.1608-1624, 2006. ,
The impact of minor blood transfusion on the outcome after coronary artery bypass grafting, J Crit Care. août, vol.40, pp.207-219, 2017. ,
The Association of Perioperative Red Blood Cell Transfusions and Decreased Long-Term Survival After Cardiac Surgery, Anesth Analg. juin, vol.108, issue.6, pp.1741-1747, 2009. ,
, Transfusion de globules rouges homologues, 2014.
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage, JAMA, vol.316, p.2025, 2016. ,
Association Between Ratio of Fresh Frozen Plasma to Red Blood Cells During Massive Transfusion and Survival Among Patients Without Traumatic Injury, JAMA Surg. 1 juin, vol.152, issue.6, p.574, 2017. ,
Variation in transfusion rates within a single institution: Exploring the effect of differing practice patterns on the likelihood of blood product transfusion in patients undergoing cardiac surgery, J Thorac Cardiovasc Surg. janv, vol.149, issue.1, pp.297-302, 2015. ,
Transfusion practice varies widely in cardiac surgery: Results from a national registry, J Thorac Cardiovasc Surg. mai, vol.147, issue.5, pp.1684-1690, 2014. ,
Prothrombin Complex Concentrate in Cardiac Surgery: A Systematic Review and Meta-Analysis, Ann Thorac Surg. avr, vol.107, issue.4, pp.1275-83, 2019. ,
The ACTA PORT-score for predicting perioperative risk of blood transfusion for adult cardiac surgery, Br J Anaesth. sept, vol.119, issue.3, pp.394-401, 2017. ,
Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score, Vox Sang. mai, vol.96, issue.4, pp.324-356, 2009. ,
Trends in blood utilization in United States cardiac surgical patients: Blood Utilization in Cardiac Surgery, Transfusion (Paris). avr, vol.55, issue.4, pp.805-819, 2015. ,
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery, N Engl J Med, vol.377, issue.22, pp.2133-2177, 2017. ,
Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery, Crit Care ,
Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery, Interact Cardiovasc Thorac Surg. 1 sept, vol.15, issue.3, pp.382-391, 2012. ,
Double-Blinded, Placebo-Controlled Trial of Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery, J Am Heart Assoc ,
Freshfrozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study: FFP and Cardiac Surgery Mortality. Transfusion (Paris), avr, vol.54, issue.4, pp.1114-1138, 2014. ,
Liberal or Restrictive Transfusion after Cardiac Surgery, N Engl J Med. 12 mars, vol.372, issue.11, pp.997-1008, 2015. ,
Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d'intérêt en hémostase périopératoire (GIHP) et du Groupe français d'études sur l'hémostase et la thrombose (GFHT) en collaboration avec la Société française d'anesthésie-réanimation (SFAR), vol.4, pp.548-62, 2018. ,
Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d'intérêt en hémostase périopératoire (GIHP) -septembre 2015, Anesth Réanimation. déc, vol.2, issue.6, pp.414-434, 2016. ,
Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study, Eur J Anaesthesiol, vol.28, issue.11, pp.796-801, 2011. ,
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients VI ,
Activation of the Hemostatic System During Cardiopulmonary Bypass, Anesth Analg. déc, vol.113, issue.6, pp.1319-1352, 2011. ,
,
The ACTA PORT-score for predicting perioperative risk of blood transfusion for adult cardiac surgery, Br J Anaesth. sept, vol.119, issue.3, pp.394-401, 2017. ,
,
A survey of the demographics of blood use, Transfus Med. févr, vol.17, issue.1, pp.1-15, 2007. ,
Trends in blood utilization in United States cardiac surgical patients: Blood Utilization in Cardiac Surgery, Transfusion (Paris). avr, vol.55, issue.4, pp.805-819, 2015. ,
The Prevalence and Impact of Preoperative Anemia in Patients Undergoing Cardiac Surgery for Rheumatic Heart Disease, J Cardiothorac Vasc Anesth. août, vol.30, issue.4, pp.896-900, 2016. ,
The incidence and importance of anaemia in patients undergoing cardiac surgery in the UK -the first Association of Cardiothoracic Anaesthetists national audit, Anaesthesia. juin, vol.71, issue.6, pp.627-662, 2016. ,
Does the severity of preoperative anemia or blood transfusion have a stronger impact on longterm survival after cardiac surgery?, J Thorac Cardiovasc Surg, vol.152, issue.5, pp.1412-1432, 2016. ,
Meta-analysis of the association between preoperative anaemia and mortality after surgery: Preoperative anaemia and mortality after surgery, Br J Surg, vol.102, issue.11, pp.1314-1338, 2015. ,
Risk Associated With Preoperative Anemia in Cardiac Surgery: A Multicenter Cohort Study, Circulation. 29 janv, vol.117, issue.4, pp.478-84, 2008. ,
The Effect of Preoperative Anemia on the Outcome After Coronary Surgery, World J Surg. juill, vol.41, issue.7, pp.1910-1918, 2017. ,
Physiologic aspects of anemia, Crit Care Clin. avr, vol.20, issue.2, pp.187-212, 2004. ,
, Recommandations de bonne pratique, Transfusion de globules rouges homologues, 2014.
, Recommandations de bonne pratique, Transfusion de Plasma thérapeutique, HAS, 2012.
, Recommandations de bonne pratique, Transfusion de plaquettes, HAS, 2016.
, Noninfectious Serious Hazards of Transfusion: Anesth Analg. mars, vol.108, issue.3, pp.759-69, 2009.
Analysis of Transfusion-Related Acute Lung Injury and Possible Transfusion-Related Acute Lung Injury Reported to the French Hemovigilance Network From, Transfus Med Rev. janv, vol.32, issue.1, pp.16-27, 2007. ,
Dix-sept ans d'hémovigilance en France : bilan, perspectives, Transfus Clin Biol. avr, vol.18, issue.2, pp.140-50, 2011. ,
Duration of Red-Cell Storage and Complications after Cardiac Surgery, N Engl J Med. 20 mars, vol.358, issue.12, pp.1229-1268, 2008. ,
Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery, Br J Anaesth. mai, vol.106, issue.5, pp.643-652, 2011. ,
Effects of Red-Cell Storage Duration on Patients Undergoing Cardiac Surgery, N Engl J Med. 9 avr, vol.372, issue.15, pp.1419-1448, 2015. ,
The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study: Comparative Effectiveness of a Time-Varying Treatment With Competing Risks, JAMA Surg. 1 févr, vol.148, issue.2, p.127, 2013. ,
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma: The PROPPR Randomized Clinical Trial, JAMA. 3 févr, vol.313, issue.5, p.471, 2015. ,
Massive Transfusion in Cardiac Surgery: The Impact of Blood Component Ratios on Clinical Outcomes and Survival, Anesth Analg. juin, vol.124, issue.6, pp.1777-82, 2017. ,
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery. Circulation, vol.116, pp.2544-52, 2007. ,
Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting*, Crit Care Med. juin, vol.34, issue.6, pp.1608-1624, 2006. ,
The Association of Perioperative Red Blood Cell Transfusions and Decreased Long-Term Survival After Cardiac Surgery, Anesth Analg. juin, vol.108, issue.6, pp.1741-1747, 2009. ,
The impact of minor blood transfusion on the outcome after coronary artery bypass grafting, J Crit Care. août, vol.40, pp.207-219, 2017. ,
Patient Blood Management: a multidisciplinary strategy to reduce the need for allogeneic blood, p.6 ,
Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage, JAMA, vol.316, p.2025, 2016. ,
Platelet Transfusion in Critical Care and Surgery: Evidence-Based Review of Contemporary Practice and Future Directions, SHOCK. mai, vol.47, issue.5, pp.537-586, 2017. ,
PRO: Prothrombin Complex Concentrate Should Be Used in Preference to Fresh Frozen Plasma for Hemostasis in Cardiac Surgical Patients, J Cardiothorac Vasc Anesth. avr, vol.32, issue.2, pp.1062-1069, 2018. ,
Development and validation of Transfusion Risk Understanding Scoring Tool (TRUST) to stratify cardiac surgery patients according to their blood transfusion needs, Transfusion (Paris). juill, vol.46, issue.7, pp.1120-1129, 2006. ,
Predicting transfusions in cardiac surgery: the easier, the better: the Transfusion Risk and Clinical Knowledge score, Vox Sang. mai, vol.96, issue.4, pp.324-356, 2009. ,
The Papworth Bleeding Risk Score: a stratification scheme for identifying cardiac surgery patients at risk of excessive early postoperative bleeding, Eur J Cardiothorac Surg. juin, vol.39, issue.6, pp.924-954, 2011. ,
Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consensus Conference on Transfusion Outcomes, Transfus Med Rev. juill, vol.25, issue.3, pp.232-246, 2011. ,
Variability in Blood and Blood Component Utilization as Assessed by an Anesthesia Information Management System, Anesthesiology. juill, vol.117, issue.1, pp.99-106, 2012. ,
Restrictive or Liberal Red-Cell Transfusion for Cardiac Surgery, N Engl J Med, vol.377, issue.22, pp.2133-2177, 2017. ,
Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery, Crit Care ,
Prothrombin Complex Concentrate in Cardiac Surgery: A Systematic Review and Meta-Analysis, Ann Thorac Surg. avr, vol.107, issue.4, pp.1275-83, 2019. ,
Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery, Interact Cardiovasc Thorac Surg. 1 sept, vol.15, issue.3, pp.382-391, 2012. ,
Double-Blinded, Placebo-Controlled Trial of Fibrinogen Concentrate Supplementation After Complex Cardiac Surgery, J Am Heart Assoc ,
Fibrinogen Concentrate in Cardiovascular Surgery: A Meta-analysis of Randomized Controlled Trials, Anesth Analg. sept, vol.127, issue.3, pp.612-633, 2018. ,
Fresh-frozen plasma transfusion did not reduce 30-day mortality in patients undergoing cardiopulmonary bypass cardiac surgery with excessive bleeding: the PLASMACARD multicenter cohort study: FFP and Cardiac Surgery Mortality. Transfusion (Paris), avr, vol.54, issue.4, pp.1114-1138, 2014. ,
Liberal or Restrictive Transfusion after Cardiac Surgery, N Engl J Med. 12 mars, vol.372, issue.11, pp.997-1008, 2015. ,
Variation in transfusion rates within a single institution: Exploring the effect of differing practice patterns on the likelihood of blood product transfusion in patients undergoing cardiac surgery, J Thorac Cardiovasc Surg. janv, vol.149, issue.1, pp.297-302, 2015. ,
Transfusion practice varies widely in cardiac surgery: Results from a national registry, J Thorac Cardiovasc Surg. mai, vol.147, issue.5, pp.1684-1690, 2014. ,
Gestion des agents antiplaquettaires pour une procédure invasive programmée. Propositions du Groupe d'intérêt en hémostase périopératoire (GIHP) et du Groupe français d'études sur l'hémostase et la thrombose (GFHT) en collaboration avec la Société française d'anesthésie-réanimation (SFAR), vol.4, pp.548-62, 2018. ,
Gestion des anticoagulants oraux directs pour la chirurgie et les actes invasifs programmés : propositions réactualisées du Groupe d'intérêt en hémostase périopératoire (GIHP) -septembre 2015, Anesth Réanimation. déc, vol.2, issue.6, pp.414-434, 2016. ,
Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study, Eur J Anaesthesiol, vol.28, issue.11, pp.796-801, 2011. ,
The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial, Interact Cardiovasc Thorac Surg. 1 déc, vol.15, issue.6, pp.1013-1021, 2012. ,
Efficacy and Safety of Erythropoietin and Intravenous Iron in Perioperative Blood Management: A Systematic Review, Transfus Med Rev, vol.27, issue.4, pp.221-255, 2013. ,
Effects of Preoperative Intravenous Erythropoietin Plus Iron on Outcome in Anemic Patients After Cardiac Valve Replacement, Am J Cardiol, vol.110, issue.7, pp.1021-1027, 2012. ,
Diagnosis and management of iron deficiency anaemia: a clinical update, Clin UPDATE, vol.193, issue.9, p.8, 2010. ,
Implementing a protocol to optimize blood use in a cardiac surgery service: results of a pre-post analysis and the impact of high-volume blood users: RESULTS OF A BLOOD TRANSFUSION PROTOCOL. Transfusion (Paris), vol.57, pp.2483-2492, 2017. ,
Firstline Therapy with Coagulation Factor Concentrates Combined with Point-of-Care Coagulation Testing Is Associated with Decreased Allogeneic Blood Transfusion in Cardiovascular SurgeryA Retrospective, Single-center Cohort Study, Anesthesiol J Am Soc Anesthesiol. 1 déc, vol.115, issue.6, pp.1179-91, 2011. ,
Pointof-care thromboelastography/thromboelastometry-based coagulation management in cardiac surgery: a meta-analysis of 8332 patients, J Surg Res. juin, vol.203, issue.2, pp.424-457, 2016. ,
,
Patient blood management in cardiac surgery results in fewer transfusions and better outcome: Patient Blood Management in Cardiac Surgery, Transfusion (Paris). mai, vol.55, issue.5, pp.1075-81, 2015. ,
Blood Transfusion Reduction in Cardiac Surgery: Multidisciplinary Approach at a Community Hospital, Ann Thorac Surg. févr, vol.87, issue.2, pp.532-541, 2009. ,
Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery: updated systematic review and meta-analysis, Br J Anaesth. juin, vol.118, issue.6, pp.823-856, 2017. ,
,
, Au moment d'être admis à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité
, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux
, Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies
, Même sous la contrainte, je ne ferai pas usage de mes connaissances contre les lois de l'humanité
, J'informerai les patients des décisions envisagées, de leurs raisons et de leurs
, Reçu à l'intérieur des maisons, je respecterai les secrets des foyers et ma conduite ne servira pas à corrompre les moeurs
, Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément
, Je n'entreprendrai rien qui dépasse mes compétences. Je les entretiendrai et les perfectionnerai pour assurer au mieux les services qui me seront demandés
, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité
, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses ; que je sois déshonoré(e) et méprisé(e) si j'y manque